Netflix Brought Back the Reboot, But Now It's Shifting Strategy
Netflix may have brought back the reboot, but now the streaming service seems to be leaving that strategy behind.
“It’s funny because Netflix really did start the trend with ‘Fuller House,’ the continuation of the 90s sitcom from ABC,” Michael O'Connell, reporter at Hollywood Reporter, told Cheddar.
“But now it seems that Netflix is kind of shying away from this. They don’t want to be in the business of saving shows or working with other people’s intellectual property. They want to do their own thing.”
That seems apparent from recent reports, which say Netflix plans to roll out 700 original movies and shows this year, according to Variety. Eighty international productions are also on the docket. The company will spend up to $8 billion to fund these projects this year.
CFO David Wells said the push is meant to expand the company’s subscriber base. In its last earnings report, Netflix said it hit nearly 118 million paying users, more than half of whom are overseas.
For the full interview, [click here](https://cheddar.com/videos/hollywoods-reboot-revolution).
President Joe Biden and Chinese President Xi Jinping have discussed Taiwan, artificial intelligence and security issues in a call meant to demonstrate a return to regular leader-to-leader dialogue between the two powers.
April is Earth month, and while the green revolution might feel far away, the founder of climate VC Siam Capital says it’s on it’s way, and, even better: it won't cost you more.
From snow in April to heatwaves in December, it’s hard to plan a trip in a climate change world. Startup Sensible Weather thinks weather-based travel reimbursements are the solution.
Between corporate debt and the widening gap between ‘the haves and the have nots,’ there are reasons to be cautious about the economy, even with interest rate cuts on their way.
If the A.I. hype hasn’t given you enough of a reason to be excited (and a little terrified), the CEO of Zapata AI says the next frontier is designing bridges or creating pharmaceutical drugs.
